CIRIUS THERAPEUTICS, INC.

Profile

Company Names

CIRIUS THERAPEUTICS, INC.

Addresses

3133 ORCHARD VISTA DR. SW, GRAND RAPIDS, MI 48390

12651 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO, CA 92130

161 E MICHIGAN AVE, SUITE 400, KALAMAZOO, MI 49007

Phone Numbers

616-450-5552
858-333-6274
616-450-1613

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$49,599,975.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2025-10-07 
$800,000.00 
$1,200,000.00 
$400,000.00 
Debt 
5
2024-10-08 
$1,000,000.00 
$1,600,000.00 
$600,000.00 
Debt 
4
2024-07-12 
$1,300,000.00 
$1,300,000.00 
$0.00 
Debt 
3
2019-05-06 
$7,499,972.00 
$7,499,972.00 
$0.00 
Equity 
2
2018-08-23 
$9,000,000.00 
$9,000,000.00 
$0.00 
Equity 
1
2017-03-24 
$30,000,003.00 
$40,500,000.00 
$10,499,997.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
BALTERA 
EXECUTIVE OFFICER, DIRECTOR
ORGANOVO, INC.   |  CIRIUS THERAPEUTICS, INC.   |  IMAGO BIOSCIENCES, INC.
ROBERT 
 
BEARDSLEY 
EXECUTIVE OFFICER
KEMPHARM INC   |  CONFLUENCE LIFE SCIENCES, INC.   |  GALERA THERAPEUTICS, INC.   |  EPIGENETX, LLC   |  PINEWOOD PARK INVESTORS, LLC   |  LSC SOLANO, LLC   |  LSC HOLLISTER, LLC   |  CIRIUS THERAPEUTICS, INC.
ROBERT 
A 
BEARDSLEY 
EXECUTIVE OFFICER
CIRIUS THERAPEUTICS, INC.
BALTERA 
 
BOB 
EXECUTIVE OFFICER, DIRECTOR
CIRIUS THERAPEUTICS, INC.
JERRY 
 
CALLAHAN 
EXECUTIVE OFFICER
GRAM NEWCO, INC.   |  CIRIUS THERAPEUTICS, INC.
HOWARD 
 
DITTRICH 
EXECUTIVE OFFICER
IOWA APPROACH, INC.   |  CHANRX CORP.   |  LAGUNA PHARMACEUTICALS, INC.   |  CIRIUS THERAPEUTICS, INC.
DANIEL 
 
ESTES 
DIRECTOR
OUTPOST MEDICINE, LLC   |  CIRIUS THERAPEUTICS, INC.   |  ARCUTIS BIOTHERAPEUTICS, INC.   |  SUDO BIOSCIENCES, INC.   |  EYCONIS, INC.
DANIEL 
 
ESTES, PH.D. 
DIRECTOR
CIRIUS THERAPEUTICS, INC.   |  LENGO THERAPEUTICS, INC.
BRIAN 
 
FARMER 
EXECUTIVE OFFICER
LAGUNA PHARMACEUTICALS, INC.   |  CIRIUS THERAPEUTICS, INC.
DENNIS 
 
FENTON, PH.D. 
DIRECTOR
CIRIUS THERAPEUTICS, INC.
MICHAEL 
 
JANDERNOA 
DIRECTOR
METABOLIC SOLUTIONS DEVELOPMENT CO   |  METABOLIC SOLUTIONS DEVELOPMENT CO LLC   |  OCTETA THERAPEUTICS, LLC   |  CIRIUS THERAPEUTICS, INC.
NILESH 
 
KUMAR 
DIRECTOR
AUXOGYN INC   |  AUXOGYN, INC.   |  TARVEDA THERAPEUTICS, INC.   |  RGENIX, INC.   |  CIRIUS THERAPEUTICS, INC.   |  MILESTONE PHARMACEUTICALS INC.   |  MORPHIC HOLDING, LLC
NILESH 
 
KUMAR, PH.D. 
DIRECTOR
CIRIUS THERAPEUTICS, INC.
MARK 
 
OLESNAVAGE 
EXECUTIVE OFFICER
TOLERA THERAPEUTICS INC   |  METABOLIC SOLUTIONS DEVELOPMENT CO   |  METABOLIC SOLUTIONS DEVELOPMENT CO LLC   |  INTERVENTION INSIGHTS, INC.   |  HOPEN LIFE SCIENCE FUND II LP   |  CIRIUS THERAPEUTICS, INC.
ELAINE 
 
SUN 
DIRECTOR
SUTROVAX, INC.   |  CIRIUS THERAPEUTICS, INC.   |  ASHER BIOTHERAPEUTICS, INC.
DAVID 
 
VAN ANDEL 
DIRECTOR
IDEA SPHERE INC   |  OCTETA THERAPEUTICS, LLC   |  CIRIUS THERAPEUTICS, INC.
ROBERT 
 
ZERBE 
DIRECTOR
METABOLEX, INC.   |  AP PHARMA INC /DE/   |  EDGEMONT PHARMACEUTICALS, LLC   |  METABOLIC SOLUTIONS DEVELOPMENT CO LLC   |  OCTETA THERAPEUTICS, LLC   |  CIRIUS THERAPEUTICS, INC.
ROBERT 
 
ZERBE, M.D. 
DIRECTOR
CIRIUS THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-10-08
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2025-10-07 
2024-10-15
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2024-10-08 
2024-08-20
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2024-07-12 
2019-05-14
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-05-06 
2018-08-30
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-23 
2017-04-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#